Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
BMC Immunol ; 22(1): 55, 2021 08 11.
Article in English | MEDLINE | ID: mdl-34380434

ABSTRACT

BACKGROUND: Cancer immunotherapy has gained increasing popularity as a novel approach to treat cancer. A member of the B7 family, V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel immune checkpoint that regulates a broad spectrum of immune responses. VISTA is an acidic pH-selective ligand for P-selectin glycoprotein ligand-1(PSGL-1). CA-170, a first-in-class small-molecule dual antagonist of VISTA/PD-L1, was collaboratively developed by Aurigene Discovery Technologies Limited and Curis, Inc. It is currently in Phase I clinical trial. RESULTS: In this study, we develop homology modeling for the VISTA 3D structure and subsequent virtual screening for VISTA small-molecule hit ligands. Visualization of the binding postures of docked ligands with the VISTA protein indicates that some small molecular compounds target VISTA. The ability of antagonist to disrupt immune checkpoint VISTA pathways was investigated though functional studies in vitro. CONCLUSIONS: Affinity active molecule for VISTA was obtained through virtual screening, and the antagonist compound activity to VISTA was assayed in cellular level. We reported a small molecule with high VISTA affinity as antagonist, providing ideas for development VISTA-targeted small molecule compound in cancer immunotherapy.


Subject(s)
Immune Checkpoint Inhibitors/pharmacology , Immunologic Factors/pharmacology , Membrane Glycoproteins/agonists , Membrane Proteins/antagonists & inhibitors , Neoplasms/therapy , Animals , B7-H1 Antigen/antagonists & inhibitors , Humans , Immune Checkpoint Inhibitors/chemistry , Immunologic Factors/chemistry , Immunotherapy , Ligands , Mice , Mice, Inbred C57BL , Molecular Docking Simulation , Neoplasms/immunology , Protein Binding , Structural Homology, Protein
3.
J Transl Med ; 13: 183, 2015 Jun 06.
Article in English | MEDLINE | ID: mdl-26047940

ABSTRACT

BACKGROUND: Early acute kidney injury (AKI) in severely burned patients predicts a high mortality that is multi-factorial. Hydrogen has been reported to alleviate organ injury via selective quenching of reactive oxygen species. This study investigated the potential protective effects of hydrogen against severe burn-induced early AKI in rats. METHODS: Severe burn were induced via immersing the shaved back of rats into a 100°C bath for 15 s. Fifty-six Sprague-Dawley rats were randomly divided into Sham, Burn + saline, and Burn + hydrogen-rich saline (HS) groups, and renal function and the apoptotic index were measured. Kidney histopathology and immunofluorescence staining, quantitative real-time PCR, ELISA and western blotting were performed on the sera or renal tissues of burned rats to explore the underlying effects and mechanisms at varying time points post burn. RESULTS: Renal function and tubular apoptosis were improved by HS treatment. In addition, the oxidation-reduction potential and malondialdehyde levels were markedly reduced with HS treatment, whereas endogenous antioxidant enzyme activities were significantly increased. HS also decreased the myeloperoxidase levels and influenced the release of inflammatory mediators in the sera and renal tissues of the burned rats. The regulatory effects of HS included the inhibition of p38, JNK, ERK and NF-κB activation, and an increase in Akt phosphorylation. CONCLUSION: Hydrogen can attenuate severe burn-induced early AKI; the mechanisms of protection include the inhibition of oxidative stress induced apoptosis and inflammation, which may be mediated by regulation of the MAPKs, Akt and NF-κB signalling pathways.


Subject(s)
Acute Kidney Injury/drug therapy , Apoptosis , Burns/drug therapy , Hydrogen/therapeutic use , Inflammation/pathology , Oxidative Stress , Sodium Chloride/therapeutic use , Acute Kidney Injury/blood , Acute Kidney Injury/complications , Acute Kidney Injury/pathology , Acute-Phase Proteins , Animals , Apoptosis/drug effects , Blotting, Western , Burns/blood , Burns/complications , Burns/pathology , Creatinine/blood , Hydrogen/pharmacology , Immunohistochemistry , Inflammation/complications , Inflammation Mediators/metabolism , Kidney Tubules/drug effects , Kidney Tubules/pathology , Lipocalin-2 , Lipocalins/blood , Male , Models, Biological , Oxidative Stress/drug effects , Peroxidase/metabolism , Proto-Oncogene Proteins/blood , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , Sodium Chloride/pharmacology
4.
PLoS One ; 10(4): e0124897, 2015.
Article in English | MEDLINE | ID: mdl-25874619

ABSTRACT

INTRODUCTION: Deep burn wounds undergo a dynamic process known as wound progression that results in a deepening and extension of the initial burn area. The zone of stasis is more likely to develop more severe during wound progression in the presence of hypoperfusion. Hydrogen has been reported to alleviate injury triggered by ischaemia/reperfusion and burns in various organs by selectively quenching oxygen free radicals. The aim of this study was to investigate the possible protective effects of hydrogen against early burn-wound progression. METHODS: Deep-burn models were established through contact with a boiled, rectangular, brass comb for 20 s. Fifty-six Sprague-Dawley rats were randomly divided into sham, burn plus saline, and burn plus hydrogen-rich saline (HS) groups with sacrifice and analysis at various time windows (6 h, 24 h, 48 h) post burn. Indexes of oxidative stress, apoptosis and autophagy were measured in each group. The zone of stasis was evaluated using immunofluorescence staining, ELISA, and Western blot to explore the underlying effects and mechanisms post burn. RESULTS: The burn-induced increase in malondialdehyde was markedly reduced with HS, while the activities of endogenous antioxidant enzymes were significantly increased. Moreover, HS treatment attenuated increases in apoptosis and autophagy postburn in wounds, according to the TUNEL staining results and the expression analysis of Bax, Bcl-2, caspase-3, Beclin-1 and Atg-5 proteins. Additionally, HS lowered the level of myeloperoxidase and expression of TNF-α, IL-1ß, and IL-6 in the zone of stasis while augmenting IL-10. The elevated levels of Akt phosphorylation and NF-κB p65 expression post burn were also downregulated by HS management. CONCLUSION: Hydrogen can attenuate early wound progression following deep burn injury. The beneficial effect of hydrogen was mediated by attenuating oxidative stress, which inhibited apoptosis and inflammation, and the Akt/NF-κB signalling pathway may be involved in regulating the release of inflammatory cytokines.


Subject(s)
Burns/prevention & control , Hydrogen/pharmacology , Inflammation/prevention & control , Sodium Chloride/pharmacology , Wound Healing/drug effects , Animals , Burns/pathology , Disease Progression , Inflammation/pathology , Male , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Signal Transduction
5.
J Zhejiang Univ Sci B ; 14(3): 224-30, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23463765

ABSTRACT

OBJECTIVE: The present study was designed to use an in vivo rabbit ear scar model to investigate the efficacy of systemic administration of endostatin in inhibiting scar formation. METHODS: Eight male New Zealand white rabbits were randomly assigned to two groups. Scar model was established by making six full skin defect wounds in each ear. For the intervention group, intraperitoneal injection of endostatin was performed each day after the wound healed (about 15 d post wounding). For the control group, equal volume of saline was injected. Thickness of scars in each group was measured by sliding caliper and the scar microcirculatory perfusion was assessed by laser Doppler flowmetry on Days 15, 21, 28, and 35 post wounding. Rabbits were euthanatized and their scars were harvested for histological and proteomic analyses on Day 35 post wounding. RESULTS: Macroscopically, scars of the control group were thicker than those of the intervention group. Significant differences between the two groups were observed on Days 21 and 35 (p<0.05). Scar thickness, measured by scar elevation index (SEI) at Day 35 post wounding, was significantly reduced in the intervention group (1.09±0.19) compared with the controls (1.36±0.28). Microvessel density (MVD) observed in the intervention group (1.73±0.94) was significantly lower than that of the control group (5.63±1.78) on Day 35. The distribution of collagen fibers in scars treated with endostatin was relatively regular, while collagen fibers in untreated controls were thicker and showed disordered alignment. Western blot analysis showed that the expressions of type I collagen and Bcl-2 were depressed by injection of endostatin. CONCLUSIONS: Our results from the rabbit ear hypertrophic scar model indicate that systemic application of endostatin could inhibit local hypertrophic scar formation, possibly through reducing scar vascularization and angiogenesis. Our results indicated that endostatin may promote the apoptosis of endothelial cells and block their release of platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF), thereby controlling collagen production by fibroblasts. Blood vessel-targeted treatment may be a promising strategy for scar therapy.


Subject(s)
Cicatrix, Hypertrophic/drug therapy , Cicatrix, Hypertrophic/pathology , Disease Models, Animal , Endostatins/therapeutic use , Wound Healing/drug effects , Angiogenesis Inhibitors/therapeutic use , Animals , Cicatrix, Hypertrophic/physiopathology , Humans , Male , Rabbits , Treatment Outcome
6.
J Zhejiang Univ Sci B ; 13(5): 372-7, 2012 May.
Article in English | MEDLINE | ID: mdl-22556175

ABSTRACT

OBJECTIVE: This study was designed to evaluate the association between skin autofluorescence (AF), an indicator of advanced glycation end-products (AGEs), and foot ulcers in subjects with diabetes. METHODS: In this study, 195 Chinese diabetic subjects were examined. Their feet were examined regardless of whether an ulcer was present or not. Skin AF was measured with an AGE reader. Demographic characteristics and blood data were recorded. RESULTS: The mean values of skin AF were 2.29 ± 0.47 for subjects without foot ulcers, and 2.80 ± 0.69 for those with foot ulcers, a significant difference (P<0.05). Skin AF was strongly correlated with age and duration of diabetes. After adjusting for these factors, multivariate logistic regression showed that skin AF was independently associated with foot ulcerations. CONCLUSIONS: Skin AF is independently associated with diabetic foot ulcerations. It might be a useful screening method for foot ulceration risk of diabetic patients.


Subject(s)
Diabetic Foot/diagnosis , Diabetic Foot/metabolism , Glycation End Products, Advanced/analysis , Skin/metabolism , Spectrometry, Fluorescence/statistics & numerical data , Aged , Biomarkers/analysis , China/epidemiology , Cross-Sectional Studies , Diabetic Foot/epidemiology , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and Specificity
7.
BMC Gastroenterol ; 11: 92, 2011 Aug 25.
Article in English | MEDLINE | ID: mdl-21867527

ABSTRACT

BACKGROUND: Runt-related transcription factor 3 (RUNX3) is a member of the runt-domain family of transcription factors and has been reported to be a candidate tumor suppressor in gastric cancer. However, the association between RUNX3 promoter methylation and gastric cancer remains unclear. METHODS: We systematically reviewed studies of RUNX3 promoter methylation and gastric cancer published in English or Chinese from January 2000 to January 2011, and quantified the association between RUNX3 promoter methylation and gastric cancer using meta-analysis methods. RESULTS: A total of 1740 samples in 974 participants from seventeen studies were included in the meta-analysis. A significant association was observed between RUNX3 promoter methylation and gastric cancer, with an aggregated odds ratio (OR) of 5.63 (95%CI 3.15, 10.07). There was obvious heterogeneity among studies. Subgroup analyses (including by tissue origin, country and age), meta-regression were performed to determine the source of the heterogeneity. Meta-regression showed that the trend in ORs was inversely correlated with age. No publication bias was detected. The ORs for RUNX3 methylation in well-differentiated vs undifferentiated gastric cancers, and in intestinal-type vs diffuse-type carcinomas were 0.59 (95%CI: 0.30, 1.16) and 2.62 (95%CI: 1.33, 5.14), respectively. There were no significant differences in RUNX3 methylation in cancer tissues in relation to age, gender, TNM stage, invasion of tumors into blood vessel or lymphatic ducts, or tumor stage. CONCLUSIONS: This meta-analysis identified a strong association between methylation of the RUNX3 promoter and gastric cancer, confirming the role of RUNX3 as a tumor suppressor gene.


Subject(s)
Core Binding Factor Alpha 3 Subunit/genetics , DNA Methylation , Stomach Neoplasms/genetics , Age Factors , Humans , Odds Ratio , Promoter Regions, Genetic
8.
Zhonghua Shao Shang Za Zhi ; 27(1): 16-20, 2011 Feb.
Article in Chinese | MEDLINE | ID: mdl-21591335

ABSTRACT

OBJECTIVE: To design and construct a kind of dermal regeneration template with mesh, and to preliminarily evaluate its biological characteristics. METHODS: PLGA mesh was integrated into CCS with freeze-drying method for constructing PLGA mesh/CCS composite (PCCS). The micromorphologies and mechanical properties among PLGA mesh, CCS, and PCCS were compared. PCCS and CCS was respectively implanted into subcutaneous tissue of SD rats (PCCS and CCS groups, 9 rats in each group). The tissue samples were collected at post operation week (POW) 1, 2, and 4 for histopathological and immunohistochemical observation. Protein levels of CD68, MPO, IL-1beta, IL-10 were examined by Western blot, with expression of gray value. Data were processed with one-way analysis of variance and t test. RESULTS: Three-dimensional porous structure of PCCS was similar to that of CCS. Mechanical property of PLGA mesh and PCCS was respectively (3.07 +/- 0.10), (3.26 +/- 0.15) MPa, and they were higher than that of CCS [(0.42 +/- 0.21) MPa, F = 592.3, P < 0.0001)]. The scaffolds were filled with newly formed tissue in PCCS group at POW 2, while those in CCS group were observed at POW 4. A large accumulation of macrophages was observed in both groups, especially at POW 2, and more macrophage infiltration was observed in CCS group. The protein level of IL-10 in PCCS group at POW 2 was obviously higher than that in CCS group, while the protein levels of CD68, MPO, IL-1beta were significantly decreased as compared with those in CCS group (with t value from -4.06 to 2.89, P < 0.05 or P < 0.01). CONCLUSIONS: PCCS has excellent mechanical property with appropriate three-dimensional porous structure. Meanwhile, it can rapidly induce formation of new tissue and vascularization, and it has a prospect of serving as a dermal substitute.


Subject(s)
Lactic Acid/chemistry , Polyglycolic Acid/chemistry , Skin, Artificial , Tissue Engineering/methods , Tissue Scaffolds , Animals , Cells, Cultured , Chitosan/chemistry , Collagen/chemistry , Extracellular Matrix/chemistry , Male , Materials Testing , Polylactic Acid-Polyglycolic Acid Copolymer , Prosthesis Design , Rats , Rats, Sprague-Dawley , Regeneration
SELECTION OF CITATIONS
SEARCH DETAIL
...